BRPI0911136A2 - ensaio baseado em fluorescência para detectar compostos de modulação de "modo reverso" de trocador de sódio/cálcio (ncx) - Google Patents

ensaio baseado em fluorescência para detectar compostos de modulação de "modo reverso" de trocador de sódio/cálcio (ncx)

Info

Publication number
BRPI0911136A2
BRPI0911136A2 BRPI0911136A BRPI0911136A BRPI0911136A2 BR PI0911136 A2 BRPI0911136 A2 BR PI0911136A2 BR PI0911136 A BRPI0911136 A BR PI0911136A BR PI0911136 A BRPI0911136 A BR PI0911136A BR PI0911136 A2 BRPI0911136 A2 BR PI0911136A2
Authority
BR
Brazil
Prior art keywords
ncx
fluorescence
calcium
based assay
reverse mode
Prior art date
Application number
BRPI0911136A
Other languages
English (en)
Inventor
Manfred Frey
Sven Geibel
Thomas Licher
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of BRPI0911136A2 publication Critical patent/BRPI0911136A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/582Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872Intracellular protein regulatory factors and their receptors, e.g. including ion channels

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0911136A 2008-03-20 2009-03-13 ensaio baseado em fluorescência para detectar compostos de modulação de "modo reverso" de trocador de sódio/cálcio (ncx) BRPI0911136A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08290265A EP2103939A1 (en) 2008-03-20 2008-03-20 Fluorescence based assay to detect sodium/calcium exchanger (NCX) "reverse mode" modulating compounds
PCT/EP2009/001823 WO2009115238A1 (en) 2008-03-20 2009-03-13 Fluorescence based assay to detect sodium/calcium exchanger (ncx) "reverse mode" modulating compounds

Publications (1)

Publication Number Publication Date
BRPI0911136A2 true BRPI0911136A2 (pt) 2015-10-06

Family

ID=39591244

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911136A BRPI0911136A2 (pt) 2008-03-20 2009-03-13 ensaio baseado em fluorescência para detectar compostos de modulação de "modo reverso" de trocador de sódio/cálcio (ncx)

Country Status (13)

Country Link
US (1) US20110124033A1 (pt)
EP (2) EP2103939A1 (pt)
JP (1) JP2011529564A (pt)
KR (1) KR20100137458A (pt)
CN (1) CN101978270A (pt)
AR (1) AR070933A1 (pt)
AU (1) AU2009226681A1 (pt)
BR (1) BRPI0911136A2 (pt)
CA (1) CA2718734A1 (pt)
IL (1) IL208177A0 (pt)
MX (1) MX2010010291A (pt)
TW (1) TW201005294A (pt)
WO (1) WO2009115238A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS53748B1 (sr) 2011-09-12 2015-06-30 Sanofi Supstituisani 2-(hroman-6-iloksi)-tiazoli i njihova upotreba kao farmaceutskih sredstava
SG11201400518RA (en) 2011-09-12 2014-04-28 Sanofi Sa Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
US8912224B2 (en) 2011-09-12 2014-12-16 Sanofi Substituted 2-(chroman-6-yloxy)-thiazoles and their use as pharmaceuticals
KR101933620B1 (ko) * 2012-09-18 2018-12-28 삼성전자주식회사 소포를 검출하기 위한 조성물, 키트 및 이를 이용하여 소포를 분석하는 방법
TWI633095B (zh) 2013-03-08 2018-08-21 賽諾菲公司 經取代-6-基氧基-環烷類及其作為醫藥品之用途
CN109187504A (zh) * 2018-07-11 2019-01-11 佛山市顺德区欧罗拉生物科技有限公司 一种基于离子通道阅读器的离子转运通道活性分析方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5714666A (en) 1993-02-09 1998-02-03 Children's Hospital Of Philadelphia Measurement of intracellular calcium using bioluminescent apoaequorin expressed in mammalian cells
DK1031556T3 (da) 1997-10-20 2003-02-24 Taisho Pharmaceutical Co Ltd 2-phenoxyanilinderivater
EP1526140B1 (en) * 2002-08-01 2008-11-05 Astellas Pharma Inc. Potassium-dependent sodium-calcium exchanger
US20050112701A1 (en) * 2003-09-11 2005-05-26 Aventis Pharma Deutschland Gmbh Test system for the identification of APJ receptor ligands
JP2006045142A (ja) * 2004-08-06 2006-02-16 Taisho Pharmaceut Co Ltd NCX1阻害剤を含有する、内因性Na+ポンプ抑制物質と関連する循環障害の治療薬または診断用薬
EP1782064B1 (en) * 2004-08-19 2012-01-18 Sanofi-Aventis Deutschland GmbH Process for identification of compounds for modulating the activity of a sodium/calcium exchange transporter
TWI372749B (en) * 2005-03-10 2012-09-21 Theravance Inc Crystalline forms of a biphenyl compound
CA2618791C (en) * 2005-08-12 2014-05-13 Riken Novel mucin-type glycoprotein and use thereof
CA2634147A1 (en) * 2005-12-22 2007-06-28 Icagen, Inc. Calcium channel antagonists
EP2103944A1 (en) * 2008-03-20 2009-09-23 sanofi-aventis Fluorescence based assay to detect sodium/calcium exchanger "forward mode" modulating compounds

Also Published As

Publication number Publication date
AR070933A1 (es) 2010-05-12
WO2009115238A1 (en) 2009-09-24
EP2103939A1 (en) 2009-09-23
CA2718734A1 (en) 2009-09-24
KR20100137458A (ko) 2010-12-30
MX2010010291A (es) 2010-10-07
IL208177A0 (en) 2010-12-30
US20110124033A1 (en) 2011-05-26
TW201005294A (en) 2010-02-01
JP2011529564A (ja) 2011-12-08
EP2257812A1 (en) 2010-12-08
AU2009226681A1 (en) 2009-09-24
CN101978270A (zh) 2011-02-16

Similar Documents

Publication Publication Date Title
LTC2004635I2 (lt) Pakeistieji enaminokarbonilo junginiai
DE602006009656D1 (de) 1-ä(3-hydroxy-adamant-1-ylamino)-acetylü-pyrrolidin-2(s)-carbonitril-formulierung mit modifizierter freisetzung
BRPI0923786A2 (pt) compostos 5,6-dihidro-6-fenilbenzo(f) isoquinolina-2- amina substituidos
BRPI0819410A2 (pt) "dispositivo com múltiplas camadas para detecção de analitos"
CR10701A (es) Compuestos de biaril eter urea
BRPI0818253A2 (pt) Moduladores de gpr40 bifenil substituídos
EP2013196A4 (en) DISUBSTITUTED ANILINE COMPOUNDS
PT3699162T (pt) Heterodímeros de ácido glutâmico
EP2044055A4 (en) amide compounds
BRPI0922904A2 (pt) "compostos"
BRPI0820344A2 (pt) Adesivos de dispersão i
ATE530523T1 (de) (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)- essigsäurederivate
EP2129224A4 (en) 5,6-dihydro-1H-pyridin-2-one compounds
EP1756013A4 (en) BIOELECTROLYTIC METHANOGENE / METHANOTROPHIC COUPLING FOR THE BIODEGRADATION OF GROUNDWATER
BRPI0714764A2 (pt) Derivados substituídos de sulfonamida
BRPI0811017A2 (pt) Lipoaspiração baseada na liquefação de tecido.
BRPI0911136A2 (pt) ensaio baseado em fluorescência para detectar compostos de modulação de "modo reverso" de trocador de sódio/cálcio (ncx)
EP2129285A4 (en) Analyte sensor
DE602007005576D1 (de) Reißnagelanhängungen
IL202235A0 (en) Substituted 2-[2-(phenyl)ethylamino] alkaneamide derivatives and their use as sodium and/or calcium channel modulators
DE502006005057D1 (de) Trommelbremse
EP2000689A4 (en) UNIVERSAL EQUIVALENT CHAIN
EP2122350A4 (en) PROOF OF ANALYTES
BRPI0809076A2 (pt) Ensaio com base na fluorescência para a detecção de compostos para a modulação do trocador de sódio-cálcio (ncx) nos compostos de modulação em "modo de avanço"
EP1960358A4 (en) ANTINEOPLASTIC COMPOUNDS

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.